News

Media highlights of Eyquem Lab's research.
Peptide–RNP delivery paper highlighted by Nature Reviews Bioengineering
Read More >>
Peptide–RNP delivery paper highlighted by Nature Biomedical Engineering
Read More >>
HIT-T cell paper highlighted in Cancer Cell
Read More >>
Response to Low Antigen Density Is Improved by HLA-Independent T-cell Receptors
Read More >>
CRISPR-driven CARs
Read More >>
CRISPR genome editing and immunotherapy – the early adopter
Read More >>
CRISPR gene therapy is enhancing T-cell immunotherapy treatment of cancer and treatments in people could be available within 2 to 3 years
Read More >>
Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors
Read More >>
Using CRISPR to Supercharge Cancer-Killing Immune Cells
Read More >>
AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinical studies
Read More >>
Curing Cancer with CRISPR
Read More >>
Pancreatic cancer cells digest extracellular protein
Read More >>